微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NeuroMetrix (NASDAQ:NURO) +65%
Reneo Pharmaceuticals (NASDAQ:RPHM) +25%
Neoleukin Therapeutics (NASDAQ:NLTX) +23%
InspireMD (NASDAQ:NSPR) +16%
Chembio Diagnostics (N...查看全文
$InspireMD, Inc.(NSPR)$ 8-K - Current report Filed: 2018-01-10 AccNo: 0001493152-18-000385 Size: 53 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD, Inc.(NSPR)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-01-08 AccNo: 0001493152-18-000313 Size: 65 KB 网页链接
$InspireMD, Inc.(NSPR)$ 8-K - Current report Filed: 2018-01-08 AccNo: 0001493152-18-000307 Size: 41 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD, Inc.(NSPR)$ 8-K - Current report Filed: 2018-01-08 AccNo: 0001493152-18-000292 Size: 68 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD, Inc.(NSPR)$ DEF 14A - Other definitive proxy statements Filed: 2017-12-26 AccNo: 0001493152-17-015034 Size: 1 MB 网页链接
$InspireMD, Inc.(NSPR)$ 8-K - Current report Filed: 2017-12-22 AccNo: 0001493152-17-015011 Size: 47 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Stateme...
$InspireMD, Inc.(NSPR)$ 8-K - Current report Filed: 2017-12-18 AccNo: 0001493152-17-014711 Size: 51 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD, Inc.(NSPR)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2017-12-15 AccNo: 0001493152-17-014643 Size: 1 MB 网页链接
$InspireMD, Inc.(NSPR)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-12-14 AccNo: 0001535610-17-000098 Size: 13 KB 网页链接
$InspireMD, Inc.(NSPR)$ 8-K - Current report Filed: 2017-12-12 AccNo: 0001493152-17-014515 Size: 46 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Stateme...